Shire received DEA approval of their new ADHD medication, Vyvanse, on May 3, 2007. This was the final step in the process before making this medication available to the public. Vyvanse will be available, by prescription only, in July of this year. The DEA has classified this drug as a schedule II controlled substance, the same class as Ritalin and Concerta. It will be available in three dosage strengths of 30mg, 50mg, and 70mg. It is used as a once a day treatment option. For more information you can read the full press release, medication guide, and/or prescribing information. You can also sign up to receive more information about this drug and "other ADHD treatments" from Shire.
May 10, 2007
Vyvanse...a new medication for ADHD
Shire received DEA approval of their new ADHD medication, Vyvanse, on May 3, 2007. This was the final step in the process before making this medication available to the public. Vyvanse will be available, by prescription only, in July of this year. The DEA has classified this drug as a schedule II controlled substance, the same class as Ritalin and Concerta. It will be available in three dosage strengths of 30mg, 50mg, and 70mg. It is used as a once a day treatment option. For more information you can read the full press release, medication guide, and/or prescribing information. You can also sign up to receive more information about this drug and "other ADHD treatments" from Shire.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Thanks for sharing your thoughts. I love comments and feedback!